Reduced Response to Activated Protein C is Associated with Increased Risk for Cerebrovascular Disease
Ann Int Med 125:265-269, van der Bom,J.G.,et al, 1996
C-Reactive Protein Predicts Further Ischemic Events in First-Ever Transient Ischemic Attack or Stroke Patients With Intracrnial Large-Artery Occlusive Disease
Stroke 34:2463-2470, Arenillas,J.F.,et al, 2003
Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack
Stroke 32:2575-2579, Rost,N.S.,et al, 2001
Inherited Protein C Deficiency and Nonhemorrhagic Arterial Stroke in Young Adults
Neurol 41:1371-1373, Camerlingo,M.,et al, 1991
Cardiac Myxoma:A Diagnostic Challenge for the Neurologist
Neurol 26:1060, Yufe,R.,et al, 1976
Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke
NEJM 389:2413-2424, 2478, Gao,Y.et al, 2023
Stroke and the Law
Stroke 45:3141-3146, Fisher, M. & Schneider, P., 2014
Sporadic Cerebral Amyloid Angiopathy Revisited: Recent Insights Into Pathophysiology and Clinical Spectrum
JNNP 83:124-137, Charidimou,A.,et al, 2012
An unusual cause of stroke and hypoxia
BMJ 342:c7200, Bell, S.L. & Eveson, D.J., 2011
Diagnosis and management of transient ischaemic attack and ischaemic stroke in the acute phase
BMJ 342:d1938, McArthur, K.S.,et al, 2011
A Telephone Hotline for Transient Ischaemic Attack and Stroke: Prospective Audit of a Model to Improve Rapid Access to Specialist Stroke Care
BMJ 341:96-98, Kerr,E., et al, 2010
No-Go to Tissue Plasminogen Activator for Transient Ischemic Attack
Stroke 41:3005-3006, 3007, Liebeskind,D.S., 2010
Pro: Intravenous Tissue Plasminogen Activator in Stroke Patients With Rapid, Complete Recovery During Evaluation (Transient Ischemic Attack) and Evidence of Middle Cerebral Artery Occlusion
Stroke 41:3003-3004, 3007, K�hrmann,M. &Schellinger,P.D., 2010
Is Hospitalization After TIA Cost-Effective on the Basis of Treatment With tPA?
Neurol 65:1799-1801, Nguyen-Huynh,M.N. &Johnson,S.C., 2005
Two Patients With Unusual Forms of Varicella-Zoster Virus Vasculopathy
NEJM 347:1500-1503, Gilden,D.H.,et al, 2002
The Neurologic Complications of Scleromyxedema
Medicine 80:313-319, Berger,J.R.,et al, 2001
Thrombolysis in Patients with Transient Neurologic Deficits
Neurol 57:2125-2128, Lyden,P.,et al, 2001
Factors Associated with Delayed Admission to Hospital and In-Hospital Delays in Acute Stroke and TIA,A Prospective,Multicenter Study
Stroke 30:40-48, Wester,P.,et al, 1999
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
Chronic Central Nervous System Involvement in Lyme Borreliosis
Neurol 38:863-867, Kohler,J.,et al, 1988
Current Medical & Surgical Therapy for Cerebrovascular Disease
NEJM 317:1505-1516, Grotta,J.C., 1987
Cerebral Ischemia in Young Patients:Is it Assoc. with Mitral Valve Prolapse & Abnormal Platelet Activity in Vivo
Stroke 13:454-458, Scharf,R.E.,et al, 1982
Antiplatelet Therapy
NEJM 298:1403, Koch,J., 1978
A Randomized Trial of Aspirin & Sulfinpyrazone in Threatened Stroke
NEJM 299:53, , 1978
Platelet Coagulant Activities & Serum Lipids In Transient Cerebral Ischemia
NEJM 295:854, Walsh,P.N.,et al, 1976
Neurologic Manifest. of Infective Endocarditis:A Review
Stroke 4:958, Greenlee,J.E.,et al, 1973